SCHEMBL20006932

SCHEMBL20006932

c1ccc(-c2ccc(-c3ccccc3-c3cc(-c4ccccc4-c4ccc(-c5ccccn5)cc4)cc(-c4cccc(-c5cc(-c6ccccc6-c6ccc(-c7ccccn7)cc6)cc(-c6ccccc6-c6ccc(-c7ccccn7)cc6)c5)c4-c4ccc(-c5ncccn5)cc4)c3)cc2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CHEK2 O96017 1/20 0.39
PDK2 Q15119 1/20 0.39
KDM4E B2RXH2 4/20 0.38
CCR1 P32246 3/20 0.38
CCR5 P51681 3/20 0.38
CCR8 P51685 3/20 0.38
LMNA P02545 2/20 0.38
CYP1A2 P05177 2/20 0.38
POLB P06746 1/20 0.38
METAP1 P53582 1/20 0.38
BLM P54132 1/20 0.38
HIF1A Q16665 1/20 0.38
DOHH Q9BU89 1/20 0.38
P4HTM Q9NXG6 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
TP53 P04637 2/20 0.38
ALOX15 P16050 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21398063 0.89 HPGDS (0.46) GRM5NPC1RAB9ACHEK2KDM4E
SCHEMBL21264668 0.87 KDM4E (0.46) GRM5NPC1RAB9ACHEK2PDK2
SCHEMBL22563622 0.87 CHEK2 (0.41) GRM5NPC1RAB9ACHEK2PDK2
SCHEMBL19794394 0.85 KDM4E (0.52) GRM5NPC1RAB9ACHEK2PDK2
SCHEMBL20068811 0.84 CHEK2 (0.47) GRM5NPC1RAB9ACHEK2PDK2
SCHEMBL21398036 0.84 LDHA (0.42) NPC1RAB9ASMN1; SMN2
SCHEMBL19933801 0.84 KDM4E (0.52) GRM5NPC1RAB9ACHEK2PDK2
SCHEMBL21398057 0.84 HPGDS (0.43) GRM5NPC1RAB9ACHEK2PDK2
SCHEMBL21398047 0.83 TOP1 (0.40) GRM5NPC1RAB9AADRB2
SCHEMBL19933639 0.83 NPC1 (0.56) NPC1RAB9AKDM4ECYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023136457-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2023-07-20 WO disclosed
US-11136343-B2 Binuclear metal complexes for use as emitters in organic electroluminescent devices MERCK PATENT GMBH (DE) 2021-10-05 US disclosed
EP-3515925-B1 BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-10-21 EP disclosed
US-20190292210-A1 BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-09-26 US disclosed
WO-2018054798-A1 BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292210-A1 BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES AP2M1, MCU, AP3M1 GRM5 1797/4885NPC1 3230/4885RAB9A 1967/4885
US-11136343-B2 Binuclear metal complexes for use as emitters in organic electroluminescent devices AP2M1, MCU, AP3M1 GRM5 1797/4885NPC1 3230/4885RAB9A 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.